Etid klinik pou Migrèn nan New York
15 etid pou Migrèn ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
Study of EVO756 in Adults With Migraine
- Clinosis - Dent Neurologic Instite, Amherst
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- True North Neurology, Port Jefferson Station
Ap rekriteFaz 1
Laj 6 a 11 · Tout sèks · Mizajou Sep 28, 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Montefiore Medical Center, The Bronx
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 28, 2026 · NCT05156398MMA Embolization for Refractory Chronic Migraine
- University of Buffalo Medical Center, Buffalo
- Mount Sinai, New York
- Stony Brook University Medical Center, Stony Brook
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT06735833A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
- Maimonides Medical Center, Brooklyn
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT06473597Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- New York Neurology Associates, New York
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- Northwell Health IRB, Great Neck
- ak 4 plis
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Dent Neurologic Institute - Amherst /ID# 270260, Amherst
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Dent Neurological Institute, Amherst
Ap rekrite
Laj 10 a 17 · Tout sèks · Mizajou Sep 21, 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nuvance Health Institute, Kingston
- Northwell Health, Manhasset
- Mt Sinai Icahn School of Medicine, New York
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Sep 16, 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Dent Neurologic Institute - Amherst /ID# 231182, Amherst
- SUNY Upstate Medical University /ID# 239898, Syracuse
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Dent Neuro Institute, Buffalo, Amherst
- SPRI Clinical Trials, LLC, Brooklyn
- True North Neurology, Commack
- ak 4 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 20, 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- True North Neurology, Commack
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Jun 12, 2026 · NCT05164172Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
- Neuroscience Institute at Great Neck, Great Neck
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou May 22, 2026 · NCT07061847RELAXaHEAD for Headache Patients (Phase III)
- NYU Langone Health, New York
Ap rekrite
Laj 16 a 80 · Tout sèks · Mizajou Oct 10, 2025 · NCT06077838Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.